FDA Announces Actions to Restrict Sale of Fluoride Products for Children
On October 31, 2025, the Food and Drug Administration (FDA) announced new actions to limit the sale of unapproved ingestible fluoride prescription drug products for children under three years of age and for children at low or moderate risk for tooth decay.
